These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7739273)

  • 41. The risks and benefits of an Rx-to-OTC switch. The case of over-the-counter H2-blockers.
    Oster G; Huse DM; Delea TE; Colditz GA; Richter JM
    Med Care; 1990 Sep; 28(9):834-52. PubMed ID: 1976142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unraveling the effects of tier-copayment drug benefit designs.
    Curtiss FR
    J Manag Care Pharm; 2003; 9(2):177-8. PubMed ID: 14613348
    [No Abstract]   [Full Text] [Related]  

  • 43. The benefits of switching smoking cessation drugs to over-the-counter status.
    Keeler TE; Hu TW; Keith A; Manning R; Marciniak MD; Ong M; Sung HY
    Health Econ; 2002 Jul; 11(5):389-402. PubMed ID: 12112489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Geography still dictates Rx coverage for many near-poor seniors and disabled persons.
    Miller EA; Weissert WG
    J Aging Soc Policy; 2007; 19(1):77-96. PubMed ID: 17347118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of outpatient prescription drug use among Pennsylvania elderly.
    Stuart B; Ahern F; Rabatin V; Johnson A
    Health Care Financ Rev; 1991; 12(3):61-72. PubMed ID: 10113613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abuse of prescription and over-the-counter medications.
    Lessenger JE; Feinberg SD
    J Am Board Fam Med; 2008; 21(1):45-54. PubMed ID: 18178702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perverse incentives in the Medicare prescription drug benefit.
    McAdams D; Schwarz M
    Inquiry; 2007; 44(2):157-66. PubMed ID: 17850042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of long-term use of medicines with prolonged oral clearance in the elderly: a survey in north east England.
    Maguire A; Baqir W
    Br Dent J; 2000 Sep; 189(5):267-72. PubMed ID: 11048395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs.
    Daniel GW; Malone DC
    J Manag Care Pharm; 2007 Mar; 13(2):142-54. PubMed ID: 17330975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Out-of-pocket expenditures for pharmaceuticals: lessons from the Austrian household budget survey.
    Sanwald A; Theurl E
    Eur J Health Econ; 2017 May; 18(4):435-447. PubMed ID: 27137847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Access to Medicare Part D gap coverage more scarce in 2007.
    Consult Pharm; 2007 Jan; 22(1):60-1. PubMed ID: 17380599
    [No Abstract]   [Full Text] [Related]  

  • 52. Prices of over-the-counter drugs used by 15-year-old adolescents in Germany and their association with socioeconomic background.
    Italia S; Wolfenstetter SB; Brüske I; Heinrich J; Berdel D; von Berg A; Lehmann I; Standl M; Teuner CM
    BMC Public Health; 2017 Nov; 17(1):904. PubMed ID: 29178855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Demand for a Medicare prescription drug benefit: exploring consumer preferences under a managed competition framework.
    Cline RR; Mott DA
    Inquiry; 2003; 40(2):169-83. PubMed ID: 13677564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of generosity level of outpatient prescription drug coverage on prescription drug events and expenditure among older persons.
    Artz MB; Hadsall RS; Schondelmeyer SW
    Am J Public Health; 2002 Aug; 92(8):1257-63. PubMed ID: 12144981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.
    Tseng CW; Brook RH; Keeler E; Steers WN; Mangione CM
    JAMA; 2004 Aug; 292(8):952-60. PubMed ID: 15328327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines.
    Sullivan PW; Nichol MB
    Value Health; 2004; 7(4):402-12. PubMed ID: 15449632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Total and out-of-pocket expenditures for prescription drugs among older persons.
    Sambamoorthi U; Shea D; Crystal S
    Gerontologist; 2003 Jun; 43(3):345-59. PubMed ID: 12810898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prescription drug expenditures, financial burden and health plan satisfaction among medicare beneficiaries.
    Curtiss FR
    J Manag Care Pharm; 2003; 9(5):453-4, 455-6. PubMed ID: 14613446
    [No Abstract]   [Full Text] [Related]  

  • 59. An Rx for reform: a Medicare prescription drug benefit.
    Rak J
    Health Matrix Clevel; 2002; 12(2):449-505. PubMed ID: 12430363
    [No Abstract]   [Full Text] [Related]  

  • 60. Medicare and prescription drugs: prospects for reform.
    Gorin SH
    Health Soc Work; 2001 May; 26(2):115-8. PubMed ID: 11378996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.